Trademark: 87826260
Status Date
Monday, June 22, 2020
Filing Date
Thursday, March 8, 2018
Published for Opposition
Tuesday, September 25, 2018
Abandoned Date
Monday, June 22, 2020
5 Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma
42 Pharmaceutical research and development; laboratory research services relating to pharmaceuticals
Jun 22, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 22, 2020
Abandonment - No Use Statement Filed
May 4, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
May 4, 2020
Teas Change Of Correspondence Received
May 4, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 4, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 4, 2020
Teas Change Of Owner Address Received
Oct 25, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2019
Extension 2 Granted
Oct 23, 2019
Extension 2 Filed
Oct 23, 2019
Teas Extension Received
Apr 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 9, 2019
Extension 1 Granted
Apr 9, 2019
Extension 1 Filed
Apr 9, 2019
Teas Extension Received
Nov 20, 2018
Noa E-Mailed - Sou Required From Applicant
Sep 25, 2018
Official Gazette Publication Confirmation E-Mailed
Sep 25, 2018
Published For Opposition
Sep 5, 2018
Notification Of Notice Of Publication E-Mailed
Aug 21, 2018
Assigned To Lie
Aug 8, 2018
Approved For Pub - Principal Register
Aug 8, 2018
Examiner's Amendment Entered
Aug 8, 2018
Notification Of Examiners Amendment E-Mailed
Aug 8, 2018
Examiners Amendment E-Mailed
Aug 8, 2018
Examiners Amendment -Written
Apr 28, 2018
Notification Of Non-Final Action E-Mailed
Apr 28, 2018
Non-Final Action E-Mailed
Apr 28, 2018
Non-Final Action Written
Apr 26, 2018
Assigned To Examiner
Mar 15, 2018
New Application Office Supplied Data Entered In Tram
Mar 12, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
